封面
市場調查報告書
商品編碼
1671839

速溶片市場按類型、適應症、劑型、年齡層、通路和地區分類

Fast Melt Tablets Market, By Type, By Indication, By Dosage Form, By Age Group, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球速溶片市場規模估計為 62 億美元,預計到 2032 年將達到 114.1 億美元,2025 年至 2032 年的複合年成長率為 9.1%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 62億美元
效能資料 從 2020 年到 2024 年 預測期 2025 至 2032 年
預測期:2025-2032年複合年成長率: 9.10% 2032 年價值預測 114.1億美元
圖。
速溶片市場-IMG1

速溶片是口溶錠在口中瞬間崩壞、溶解,無需咀嚼或喝水。它們經過最佳化設計,可以在口中快速崩壞或溶解,使其更容易吞嚥。速溶片一般適用於吞嚥傳統錠劑或膠囊有困難的患者,如兒童、老年人、吞嚥障礙患者。速溶片旨在在口腔內溶解並釋放藥物,因此吞嚥時無需用水。此技術方便了吞嚥功能受損患者的給藥,提高了患者的遵從性。

市場動態:

全球速溶片市場的發展受到老年人口不斷成長的推動,老年人難以吞嚥傳統的錠劑和膠囊。與傳統錠劑相比,主要的阻礙因素是速溶片劑的製造成本較高。然而,預計在預測期內,提高患者依從性和易於管理等優勢(尤其是對兒科和老年患者而言)將為市場成長提供豐厚的機會。

本研究的主要特點

本報告對全球速溶片市場進行了詳細分析,並給出了預測期(2025-2032)的市場規模和年複合成長率(CAGR%),假設 2024 年為基準年。

它還揭示了各個領域的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球速溶片市場的主要企業是根據公司亮點、產品系列、關鍵亮點、性能和策略等參數進行的分析。

研究涉及的主要企業包括輝瑞公司、葛蘭素史克公司、強生公司、默克公司、諾華公司、賽諾菲公司、梯瓦製藥工業有限公司、邁蘭公司、安進公司、艾爾建公司、阿拉賓度製藥有限公司、Hikma Pharmaceuticals 公司、太陽製藥工業有限公司、Strides Pharma Science Limited 和 Zydus Cadila。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

本全球速溶片市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員將透過用於分析全球速溶片市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 促進要素
  • 限制因素
  • 機會
  • 影響分析
  • 主要進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • PORTER 分析
  • 併購情景
  • 產業趨勢

4. 2020 年至 2032 年全球速溶片市場(按類型分類)(十億美元)

  • 抗精神病藥物
  • 抗驚厥藥
  • 興奮劑
  • 抗焦慮藥物
  • 抗帕金森氏症藥物
  • 抗高血壓藥物
  • NSAIDs
  • 抗過敏藥物
  • 質子幫浦抑制劑
  • 其他

5. 全球速溶片市場,按適應症,2020-2032 年(十億美元)

  • 疼痛管理
  • 過敏和呼吸系統疾病
  • 神經系統疾病
  • 胃腸道疾病
  • 心血管疾病
  • 其他

6. 2020 年至 2032 年全球速溶片市場(以劑型分類)(十億美元)

  • 口服
  • 舌下
  • 口服
  • 咀嚼片

7. 2020 年至 2032 年全球速溶片市場(依年齡層分類)(十億美元)

  • 成人
  • 孩子們
  • 老年人

8. 全球速溶片市場,依通路,2020-2032 年(十億美元)

  • 醫院藥房
  • 零售藥局
  • 網路藥局

9. 2020 年至 2032 年全球速溶片市場,按地區分類,價值(十億美元)

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲
    • 北非
    • 中部非洲

第10章 競爭格局

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Amgen Inc.
  • Allergan plc
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.
  • Strides Pharma Science Limited
  • Zydus Cadila

第 11 章 分析師建議

  • 命運之輪
  • 分析師觀點
  • 一致的機會圖

第 12 章參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI7726

The Global Fast Melt Tablets Market is estimated to be valued at USD 6.20 Bn in 2025 and is expected to reach USD 11.41 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.20 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 11.41 Bn
Figure. Fast Melt Tablets Market Share (%), By Region, 2025
Fast Melt Tablets Market - IMG1

Fast melt tablets refer to orally disintegrating tablets that disintegrate or dissolve instantaneously in the oral cavity without chewing or the need of water. They are optimally designed to rapidly disintegrate or dissolve in the mouth, thereby facilitating swallowing. Fast melt tablets generally target patients who experience difficulties in swallowing conventional tablets and capsules such as pediatric, geriatric patients, and those with dysphagia. Rapidly dissolving tablets are designed to dissolve and release the drugs in buccal cavity eliminating the need of water for swallowing. This technology offers ease of administration to patients with impaired ability to swallow and enhances patient compliance.

Market Dynamics:

The global fast melt tablets market is driven by growing geriatric population who experience difficulty in swallowing conventional tablets and capsules. The key restraining factor includes high cost of manufacturing fast melt tablets as compared to conventional tablets. However, advantages such as enhanced patient compliance and convenience of administration especially for pediatric and geriatric patients is expected to provide lucrative opportunities for market growth over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fast melt tablets market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fast melt tablets market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Amgen Inc., Allergan plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Strides Pharma Science Limited, and Zydus Cadila

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fast melt tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fast melt tablets market

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Anti Psychotics
    • Anti Epileptics
    • CNS Stimulants
    • Anxiolytics
    • Anti Parkinsonian Drugs
    • Anti Hypertensive
    • NSAIDs
    • Anti Allergy Drugs
    • Proton Pump Inhibitors
    • Others
  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Pain Management
    • Allergy and Respiratory Disorders
    • Neurological Disorders
    • Gastrointestinal Disorders
    • Cardiovascular Disorders
    • Others
  • Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
    • Oral
    • Sublingual
    • Buccal
    • Chewable
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Adult
    • Pediatrics
    • Geriatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Novartis AG
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Amgen Inc.
    • Allergan plc
    • Aurobindo Pharma Ltd.
    • Hikma Pharmaceuticals plc
    • Sun Pharmaceutical Industries Ltd.
    • Strides Pharma Science Limited
    • Zydus Cadila

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fast Melt Tablets Market, By Type
    • Global Fast Melt Tablets Market, By Indication
    • Global Fast Melt Tablets Market, By Dosage Form
    • Global Fast Melt Tablets Market, By Age Group
    • Global Fast Melt Tablets Market, By Distribution Channel
    • Global Fast Melt Tablets Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Fast Melt Tablets Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Anti Psychotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Epileptics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • CNS Stimulants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anxiolytics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Parkinsonian Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Hypertensive
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • NSAIDs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Allergy Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Proton Pump Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Fast Melt Tablets Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Allergy and Respiratory Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiovascular Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Fast Melt Tablets Market, By Dosage Form, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Buccal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chewable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Fast Melt Tablets Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Fast Melt Tablets Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Fast Melt Tablets Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Amgen Inc.
  • Allergan plc
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.
  • Strides Pharma Science Limited
  • Zydus Cadila

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us